Jaguar Health (JAGX) Tops Q2 EPS by 3647c

Jaguar Health (NASDAQ: JAGX) reported Q2 EPS of ($15.68), $36.47 better than the analyst estimate of ($52.15). Revenue for the quarter came in at $1.23 million versus the consensus estimate of $4.24 million.

For earnings history and earnings-related data on Jaguar Health (JAGX) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Deere shares climb as fiscal Q3 earnings and revenue top estimates
• Rubrik Inc (RBRK) PT Raised to $120 at Oppenheimer; Sees Another 'Beat and Raise'